Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges

被引:116
作者
Gerhauser, Clarissa [1 ]
机构
[1] German Canc Res Ctr, Div Epigen & Canc Risk Factors, D-69120 Heidelberg, Germany
来源
NATURAL PRODUCTS IN CANCER PREVENTION AND THERAPY | 2013年 / 329卷
关键词
Cancer chemoprevention; Dietary compounds; DNA methylation; Histone modifications; Nutri-epigenetics; NF-KAPPA-B; TUMOR-SUPPRESSOR GENE; HISTONE DEACETYLASE INHIBITORS; CPG ISLAND HYPERMETHYLATION; DNA METHYLATION INHIBITORS; ABERRANT CRYPT FORMATION; GREEN TEA POLYPHENOL; CELL-CYCLE ARREST; PROSTATE-CANCER; BREAST-CANCER;
D O I
10.1007/128_2012_360
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The term "epigenetics" refers to modifications in gene expression caused by heritable, but potentially reversible, changes in DNA methylation and chromatin structure. Epigenetic alterations have been identified as promising new targets for cancer prevention strategies as they occur early during carcinogenesis and represent potentially initiating events for cancer development. Over the past few years, nutri-epigenetics - the influence of dietary components on mechanisms influencing the epigenome - has emerged as an exciting new field in current epigenetic research. During carcinogenesis, major cellular functions and pathways, including drug metabolism, cell cycle regulation, potential to repair DNA damage or to induce apoptosis, response to inflammatory stimuli, cell signalling, and cell growth control and differentiation become deregulated. Recent evidence now indicates that epigenetic alterations contribute to these cellular defects, for example epigenetic silencing of detoxifying enzymes, tumor suppressor genes, cell cycle regulators, apoptosis-inducing and DNA repair genes, nuclear receptors, signal transducers and transcription factors by promoter methylation, and modifications of histones and non-histone proteins such as p53, NF-kappa B, and the chaperone HSP90 by acetylation or methylation. The present review will summarize the potential of natural chemopreventive agents to counteract these cancer-related epigenetic alterations by influencing the activity or expression of DNA methyltransferases and histone modifying enzymes. Chemopreventive agents that target the epigenome include micronutrients (folate, retinoic acid, and selenium compounds), butyrate, polyphenols from green tea, apples, coffee, black raspberries, and other dietary sources, genistein and soy isoflavones, curcumin, resveratrol, dihydrocoumarin, nordihydroguaiaretic acid (NDGA), lycopene, anacardic acid, garcinol, constituents of Allium species and cruciferous vegetables, including indol-3-carbinol (I3C), diindolylmethane (DIM), sulforaphane, phenylethyl isothiocyanate (PEITC), phenylhexyl isothiocyanate (PHI), diallyldisulfide (DADS) and its metabolite allyl mercaptan (AM), cambinol, and relatively unexplored modulators of histone lysine methylation (chaetocin, polyamine analogs). So far, data are still mainly derived from in vitro investigations, and results of animal models or human intervention studies are limited that demonstrate the functional relevance of epigenetic mechanisms for health promoting or cancer preventive efficacy of natural products. Also, most studies have focused on single candidate genes or mechanisms. With the emergence of novel technologies such as next-generation sequencing, future research has the potential to explore nutri-epigenomics at a genome-wide level to understand better the importance of epigenetic mechanisms for gene regulation in cancer chemoprevention.
引用
收藏
页码:73 / 132
页数:60
相关论文
共 282 条
[1]
p21 in cancer: intricate networks and multiple activities [J].
Abbas, Tarek ;
Dutta, Anindya .
NATURE REVIEWS CANCER, 2009, 9 (06) :400-414
[2]
Adjakly M, 2011, EPIGENOMICS-UK, V3, P795, DOI [10.2217/EPI.11.103, 10.2217/epi.11.103]
[3]
Role of the ras-association domain family 1 tumor suppressor gene in human cancers [J].
Agathanggelou, A ;
Cooper, WN ;
Latif, F .
CANCER RESEARCH, 2005, 65 (09) :3497-3508
[4]
Molecular targets of dietary agents for prevention and therapy of cancer [J].
Aggarwal, BB ;
Shishodia, S .
BIOCHEMICAL PHARMACOLOGY, 2006, 71 (10) :1397-1421
[5]
Ursodeoxycholic acid modulates histone acetylation and induces differentiation and senescence [J].
Akare, Sandeep ;
Jean-Louis, Samira ;
Chen, Wemin ;
Wood, Daniel J. ;
Powell, Ashley A. ;
Martinez, Jesse D. .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (12) :2958-2969
[6]
A review of dietary factors and its influence on DNA methylation in colorectal carcinogenesis [J].
Arasaradnam, R. P. ;
Commane, D. M. ;
Bradburn, D. ;
Mathers, J. C. .
EPIGENETICS, 2008, 3 (04) :193-198
[7]
p21WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells [J].
Archer, SY ;
Meng, SF ;
Shei, A ;
Hodin, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) :6791-6796
[8]
Mechanism of p300 Specific Histone Acetyltransferase Inhibition by Small Molecules [J].
Arif, M. ;
Pradhan, Suman Kalyan ;
Thanuia, G. R. ;
Vedamurthy, B. M. ;
Agrawal, Shipra ;
Dasgupta, Dipak ;
Kundu, Tapas K. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (02) :267-277
[9]
The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival [J].
Balasubramanian, Sivaprakasam ;
Adhikary, Gautam ;
Eckert, Richard L. .
CARCINOGENESIS, 2010, 31 (03) :496-503
[10]
Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription [J].
Balasubramanyam, K ;
Varier, RA ;
Altaf, M ;
Swaminathan, V ;
Siddappa, NB ;
Ranga, U ;
Kundu, TK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (49) :51163-51171